Loading...
Indian Pharmaceutical Exporter · #11 for Lomustine · $2.2K export value · DGFT Verified
Ravi Pharma is the #11 Indian exporter of Lomustine with $2.2K in export value and 5 verified shipments. Ravi Pharma holds a 2.1% market share in Lomustine exports across 1 countries. The company exports 7 pharmaceutical products worth $88.1K across 2 therapeutic categories.
| UNITED ARAB EMIRATES | $8.2K | 20 | 9.1% |
| SWITZERLAND | $4.5K | 15 | 5.0% |
| POLAND | $4.4K | 7 | 5.0% |
| MAURITIUS | $4.4K | 2 | 4.9% |
| MEXICO | $4.4K | 22 | 4.9% |
| NETHERLANDS | $4.1K | 6 | 4.6% |
India exports Lomustine to 36 countries. The top destination is ITALY (14.8%), followed by BRAZIL and SRI LANKA.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| THE ESSES PHARMACY (PVT) LTD | SRI LANKA | $10.3K | 3 |
| TO THE IMPORT MANAGER | UNITED ARAB EMIRATES | $5.7K | 3 |
| TO THE IMPORTING DEPARTMENT | ITALY | $2.6K | 16 |
| TO THE CONSIGNEE- | POLAND | $2.3K | 10 |
| SKIN LINE LOGISTIC | IRAQ | $2.2K | 5 |
| TO THE, IMPORTING DEPARTMENT, | SWITZERLAND | $2.2K | 12 |
| TO THE CONSIGNEE | MALAYSIA | $2.0K | 6 |
India's Lomustine is purchased by 135 buyers worldwide. The top buyer is THE ESSES PHARMACY (PVT) LTD (SRI LANKA), followed by TO THE IMPORT MANAGER and TO THE IMPORTING DEPARTMENT.
India exported $63.2K worth of Lomustine through 399 shipments from 74 suppliers to 36 countries, serving 135 buyers globally. Ravi Pharma contributes $2.2K to this total, accounting for 2.1% of India's Lomustine exports.
Ravi Pharma's average Lomustine shipment value is $438 per consignment, based on 5 shipments totaling $2.2K.
Ravi Pharma ranks #11 among 74 Indian Lomustine exporters with a 2.1% market share. The top 3 exporters are 3S CORPORATION ($14.0K), PLEASANT EXPORTS ($10.5K), JPC GLOBAL ($7.6K). Ravi Pharma processed 5 shipments to 1 destination countries.
What Ravi Pharma must comply with to export Lomustine to its top destination countries
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | GMSANJIVANI LLP | $2.8K | 3 | 1 | $930 |
| 10 | BRUCK PHARMA PRIVATE LIMITED | $2.8K | 3 | 2 | $923 |
| 11 | RAVI PHARMA ★ | $2.2K | 5 | 1 | $438 |
| 12 | MEDINEX HEALTHCARE | $2.2K | 12 | 1 | $181 |
Ravi Pharma ranks #11 among 74 Indian Lomustine exporters. Average shipment value of $438 compared to the market average of $854. The closest competitors by value are GMSANJIVANI LLP and BRUCK PHARMA PRIVATE LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 149 | 37.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 105 | 26.3% |
| Bombay Air | 34 | 8.5% |
| DELHI AIR | 34 | 8.5% |
| Bombay Air Cargo | 21 | 5.3% |
| DELHI AIR CARGO ACC (INDEL4) | 16 | 4.0% |
| CHENNAI AIR | 6 | 1.5% |
| HYDERABAD AIR | 3 | 0.8% |
Ravi Pharma also exports these advanced oncology products. Each links to the detailed product page.
Ravi Pharma exports 7 products worth $88.1K. Beyond Lomustine, top products include Mitomycin, Ibrutinib, Ledipasvir, Cabozantinib, Regorafenib. View the complete Ravi Pharma profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Lomustine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 36+ countries, 135+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Ravi Pharma's Lomustine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Ravi Pharma
Full Company Profile →
7 products · $88.1K total trade · 2 categories
Access shipment-level records, pricing trends, and buyer contacts for Ravi Pharma.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Lomustine. For current shipment-level data, contact TransData Nexus.